SonoVascular, Inc.

SonoVascular, Inc. is a private medical device company that specializes in therapeutic ultrasound-based solutions for vascular care. The company focuses on treating venous thromboembolism (VTE), which includes conditions like deep vein thrombosis (DVT) and pulmonary embolism (PE). SonoVascular is dedicated to developing innovative technologies that enhance the safety, efficacy, and cost-effectiveness of vascular interventions. The flagship product, the SonoThrombectomy™ System, is an investigational device designed to treat VTE by delivering ultrasound energy and microbubbles directly to blood clots through a specialized catheter. This system utilizes microbubble-mediated cavitation to break down clots, combined with a low dose of tissue plasminogen activator (tPA) to improve clot dissolution. The procedure is performed in a cath lab setting, potentially reducing recovery time and healthcare costs for patients. SonoVascular recently completed a first-in-human study that showed promising results, including 100% clot reduction and significant improvements in clinical severity and pain scores. The company aims to provide safer and more effective treatment options for patients suffering from VTE, addressing a serious cardiovascular condition that affects millions in the U.S. annually.

• Employees 10
• Founded 2018